Meeting the biologic challenge of colorectal metastases

Sentinel Lymph Node Procedure Leads to Upstaging of Patients with Resectable Colon Cancer: Results of the Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer

(2012) Carsten T. Viehl et al.   ANNALS OF SURGICAL ONCOLOGY

Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA)

(2012) Ulrich Güller et al.   CANCER

Comparison of Adjuvant Systemic Chemotherapy With or Without Hepatic Arterial Infusional Chemotherapy After Hepatic Resection for Metastatic Colorectal Cancer

(2011) Michael G. House et al.   ANNALS OF SURGERY

OSNA-Based Novel Molecular Testing for Lymph Node Metastases in Colorectal Cancer Patients: Results from a Multicenter Clinical Performance Study in Japan

(2011) Hirofumi Yamamoto et al.   ANNALS OF SURGICAL ONCOLOGY

Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer

(2011) Tomo Osako et al.   CANCER

High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome

(2011) Antoine Brouquet et al.   JOURNAL OF CLINICAL ONCOLOGY

Personalized Colon Cancer Care in 2010

(2011) Daniel V.T. Catenacci et al.   SEMINARS IN ONCOLOGY

Monoclonal antibodies in the treatment of metastatic colorectal cancer: A review

(2010) Jolien Tol et al.   CLINICAL THERAPEUTICS

Role of Adjuvant Therapy After Resection of Colorectal Cancer Liver Metastases

(2010) Derek G. Power et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer

(2010) Alberto Bardelli et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic Metastases From Colorectal Cancer

(2010) Nancy E. Kemeny et al.   JOURNAL OF CLINICAL ONCOLOGY

Pathobiology of colorectal cancer hepatic metastases with an emphasis on prognostic factors

(2010) Mark P. LeGolvan et al.   JOURNAL OF SURGICAL ONCOLOGY

The neoadjuvant therapy of colorectal hepatic metastases and the role of biologic sensitizing and resistance factors

(2010) Harold J. Wanebo et al.   JOURNAL OF SURGICAL ONCOLOGY

Treatment of liver colorectal metastases: Role of laparoscopy, radiofrequency ablation, and microwave coagulation

(2010) Flavio G. Rocha et al.   JOURNAL OF SURGICAL ONCOLOGY

One Step Nucleic Acid Amplification (OSNA) - a new method for lymph node staging in colorectal carcinomas

(2010) Roland S Croner et al.   Journal of Translational Medicine

The VEGF family in cancer and antibody-based strategies for their inhibition

(2010) Laura A. Sullivan et al.   mAbs

The role of the Angiopoietins in vascular morphogenesis

(2009) Markus Thomas et al.   ANGIOGENESIS

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study

(2009) E. Van Cutsem et al.   ANNALS OF ONCOLOGY

Increased Use of Parenchymal-Sparing Surgery for Bilateral Liver Metastases From Colorectal Cancer Is Associated With Improved Mortality Without Change in Oncologic Outcome

(2009) Jason S. Gold et al.   ANNALS OF SURGERY

Liver Resection for Metastatic Colorectal Cancer in Patients with Concurrent Extrahepatic Disease: Results in 127 Patients Treated at a Single Center

(2009) Darren R. Carpizo et al.   ANNALS OF SURGICAL ONCOLOGY

Systematic Review of Randomized and Nonrandomized Trials of the Clinical Response and Outcomes of Neoadjuvant Systemic Chemotherapy for Resectable Colorectal Liver Metastases

(2009) Terence C. Chua et al.   ANNALS OF SURGICAL ONCOLOGY

Key Enzymes of the Extracellular Matrix in Colorectal Cancer

(2009) D. A. Golovkov   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies

(2009) A. Sartore-Bianchi et al.   CANCER RESEARCH

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

Integrins

(2009) Malgorzata Barczyk et al.   CELL AND TISSUE RESEARCH

The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis

(2009) Konstantinos A. Paschos et al.   CELLULAR SIGNALLING

Molecular Detection of Lymph Node Metastases in Breast Cancer Patients: Results of a Multicenter Trial Using the One-Step Nucleic Acid Amplification Assay

(2009) Y. Tamaki et al.   CLINICAL CANCER RESEARCH

Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer

(2009) Y. J. Fang et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

The engagement of selectins and their ligands in colorectal cancer liver metastases

(2009) Konstantinos A. Paschos et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer

(2009) Pierre Laurent-Puig et al.   JOURNAL OF CLINICAL ONCOLOGY

Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer

(2009) Salvatore Siena et al.   JNCI-Journal of the National Cancer Institute

Defining the role of laminin-332 in carcinoma

(2009) Cherise M. Guess et al.   MATRIX BIOLOGY

The role of floxuridine in metastatic liver disease

(2009) D. G. Power et al.   MOLECULAR CANCER THERAPEUTICS

Molecular Basis of Colorectal Cancer

(2009) Sanford D. Markowitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

(2009) Eric Van Cutsem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases

(2008) Birgit Gruenberger et al.   BMC CANCER

Amphiregulin Is a Promising Prognostic Marker for Liver Metastases of Colorectal Cancer

(2008) M. Yamada et al.   CLINICAL CANCER RESEARCH

Integrins: A Method of Early Intervention in the Treatment of Colorectal Liver Metastases

(2008) Alexander Seifalian et al.   CURRENT PHARMACEUTICAL DESIGN

Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases

(2008) Martin Illemann et al.   INTERNATIONAL JOURNAL OF CANCER

Complete Pathologic Response After Preoperative Chemotherapy for Colorectal Liver Metastases: Myth or Reality?

(2008) René Adam et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials

(2008) Emmanuel Mitry et al.   JOURNAL OF CLINICAL ONCOLOGY

Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases

(2008) Dan G. Blazer et al.   JOURNAL OF CLINICAL ONCOLOGY

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

(2008) Leonard B. Saltz et al.   JOURNAL OF CLINICAL ONCOLOGY

Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

(2008) Carsten Bokemeyer et al.   JOURNAL OF CLINICAL ONCOLOGY

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

(2008) Bernard Nordlinger et al.   LANCET

MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis

(2008) Ulrike Stein et al.   NATURE MEDICINE